| [1] | Post, D.J., Douglas, D.D., and Mulligan, D.C. (2005). Immunosuppression in liver transplantation. Liver Transpl. 11(11): 1307–1314. https://doi.org/10.1002/lt.20614. |
| [2] | Wei, X., Xie, W., Yin, W., et al. (2022). Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry. Am. J. Cancer Res. 12(9): 4160–4176. |
| [3] | Huang, H., Chen, R., Lin, Y., et al. (2023). Decoding Single-cell Landscape and Intercellular Crosstalk in the Transplanted Liver. Transplantation 107(4): 890–902. https://doi.org/10.1097/TP.0000000000004365. |
| [4] | Li, X., Li, S., Wu, B., et al. (2022). Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis. Front. Immunol. 13: 890019. https://doi.org/10.3389/fimmu.2022.890019. |
| [5] | Huang, H., Zhang, X., Zhang, C., et al. (2020). The time-dependent shift in the hepatic graft and recipient macrophage pool following liver transplantation. Cell. Mol. Immunol. 17(4): 412–414. https://doi.org/10.1038/s41423-019-0253-x. |
| [6] | Wang, L., Li, J., He, S., et al. (2021). Resolving the graft ischemia-reperfusion injury during liver transplantation at the single cell resolution. Cell Death Dis. 12(6): 589. https://doi.org/10.1038/s41419-021-03878-3. |
| [7] | Shan, Y., Qi, D., Zhang, L., et al. (2023). Single-cell RNA-seq revealing the immune features of donor liver during liver transplantation. Front. Immunol. 14: 1096733. https://doi.org/10.3389/fimmu.2023.1096733. |
| [8] | Mederacke, Y.-S., Nienen, M., Jarek, M., et al. (2021). T cell receptor repertoires within liver allografts are different from those in the peripheral blood. J. Hepatol. 74(5): 1167–1175. https://doi.org/10.1016/j.jhep.2020.12.014. |
| [9] | Wu, T., Hu, E., Xu, S., et al. (2021). clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2(3): 100141. https://doi.org/10.1016/j.xinn.2021.100141. |
| [10] | Kumar, L., and E Futschik, M. (2007). Mfuzz: a software package for soft clustering of microarray data. Bioinformation 2(1): 5–7. https://doi.org/10.6026/97320630002005. |
| [11] | Ivashkiv, L.B., and Donlin, L.T. (2014). Regulation of type Ⅰ interferon responses. Nat. Rev. Immunol. 14(1): 36–49. https://doi.org/10.1038/nri3581. |
| [12] | Obara, H., Nagasaki, K., Hsieh, C.L., et al. (2005). IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am. J. Transplant. 5(9): 2094–2103. https://doi.org/10.1111/j.1600-6143.2005.00995.x. |
| [13] | Wang, E., Worschech, A., and Marincola, F.M. (2008). The immunologic constant of rejection. Trends Immunol. 29(6): 256–262. https://doi.org/10.1016/j.it.2008.03.002. |
| [14] | Gwon, Y., Maxwell, B.A., Kolaitis, R.-M., et al. (2021). Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner. Science 372(6549): eabf6548. https://doi.org/10.1126/science.abf6548. |
| [15] | Fang, N.N., Chan, G.T., Zhu, M., et al. (2014). Rsp5/Nedd4 is the main ubiquitin ligase that targets cytosolic misfolded proteins following heat stress. Nat. Cell Biol. 16(12): 1227–1237. https://doi.org/10.1038/ncb3054. |
| [16] | Turakhiya, A., Meyer, S.R., Marincola, G., et al. (2018). ZFAND1 Recruits p97 and the 26S Proteasome to Promote the Clearance of Arsenite-Induced Stress Granules. Mol. Cell 70(5): 906–919.e7. https://doi.org/10.1016/j.molcel.2018.04.021. |
| [17] | Balagopal, V., and Parker, R. (2009). Polysomes, P bodies and stress granules: states and fates of eukaryotic mRNAs. Curr. Opin. Cell Biol. 21(3): 403–408. https://doi.org/10.1016/j.ceb.2009.03.005. |
| [18] | Shalgi, R., Hurt, J.A., Lindquist, S., et al. (2014). Widespread inhibition of posttranscriptional splicing shapes the cellular transcriptome following heat shock. Cell Rep. 7(5): 1362–1370. https://doi.org/10.1016/j.celrep.2014.04.044. |
| [19] | Thomson, A.W., Vionnet, J., and Sanchez-Fueyo, A. (2020). Understanding, predicting and achieving liver transplant tolerance: from bench to bedside. Nat. Rev. Gastroenterol. Hepatol. 17(12): 719–739. https://doi.org/10.1038/s41575-020-0334-4. |
| [20] | Ogawa, K., Hirai, M., Katsube, T., et al. (2000). Suppression of cellular immunity by surgical stress. Surgery 127(3): 329–336. https://doi.org/10.1067/msy.2000.103498. |
| [21] | Goldrath, A.W., Bogatzki, L.Y., and Bevan, M.J. (2000). Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192(4): 557–564. https://doi.org/10.1084/jem.192.4.557. |
| [22] | Lanzavecchia, A., and Sallusto, F. (2005). Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17(3): 326–332. https://doi.org/10.1016/j.coi.2005.04.010. |
| [23] | Li, Y., An, H., Shen, C., et al. (2021). Deep phenotyping of T cell populations under long-term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry. Clin. Transl. Med. 11(11): e629. https://doi.org/10.1002/ctm2.629. |
| [24] | Presser, D., Sester, U., Mohrbach, J., et al. (2009). Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens. Kidney Int. 76(5): 557–566. https://doi.org/10.1038/ki.2009.198. |
| [25] | Schwartz, R.H. (2003). T cell anergy. Annu. Rev. Immunol. 21: 305–334. https://doi.org/10.1146/annurev.immunol.21.120601.141110. |
| [26] | ElTanbouly, M.A., and Noelle, R.J. (2021). Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey. Nat. Rev. Immunol. 21(4): 257–267. https://doi.org/10.1038/s41577-020-00454-2. |
| [27] | Strom, T.B., Tilney, N.L., Carpenter, C.B., et al. (1975). Identity and cytotoxic capacity of cells infiltrating renal allografts. N. Engl. J. Med. 292(24): 1257–1263. https://doi.org/10.1056/NEJM197506122922402. |
| [28] | Kubota, N., Sugitani, M., Takano, S., et al. (2006). Correlation between acute rejection severity and CD8-positive T cells in living related liver transplantation. Transpl. Immunol. 16(1): 60–64. https://doi.org/10.1016/j.trim.2006.03.002. |
| [29] | Orr, M.T., and Lanier, L.L. (2010). Natural killer cell education and tolerance. Cell 142(6): 847–856. https://doi.org/10.1016/j.cell.2010.08.031. |
| [30] | Tai, L.-H., de Souza, C.T., Bélanger, S., et al. (2013). Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells. Cancer Res. 73(1): 97–107. https://doi.org/10.1158/0008-5472.CAN-12-1993. |
| [31] | Angka, L., Tanese de Souza, C., Baxter, K.E., et al. (2022). Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgery. Mol. Ther. 30(10): 3270–3283. https://doi.org/10.1016/j.ymthe.2022.05.024. |
| [32] | Wang, Y.-Y., Chang, E.-Q., Zhu, R.-L., et al. (2022). An atlas of dynamic peripheral blood mononuclear cell landscapes in human perioperative anaesthesia/surgery. Clin. Transl. Med. 12(1): e663. https://doi.org/10.1002/ctm2.663. |
| [33] | Kim, T.-J., Kim, N., Kang, H.J., et al. (2010). FK506 causes cellular and functional defects in human natural killer cells. J. Leukoc. Biol. 88(6): 1089–1097. https://doi.org/10.1189/jlb.0310148. |
| [34] | Wang, H., Grzywacz, B., Sukovich, D., et al. (2007). The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood 110(5): 1530–1539. https://doi.org/10.1182/blood-2006-10-048173. |
| [35] | Kitchens, W.H., Uehara, S., Chase, C.M., et al. (2006). The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 81(6): 811–817. https://doi.org/10.1097/01.tp.0000202844.33794.0e. |
| [36] | Knorr, D.A., Bachanova, V., Verneris, M.R., et al. (2014). Clinical utility of natural killer cells in cancer therapy and transplantation. Semin. Immunol. 26(2): 161–172. https://doi.org/10.1016/j.smim.2014.02.002. |
| [37] | Cooper, M.A., Fehniger, T.A., and Caligiuri, M.A. (2001). The biology of human natural killercell subsets. Trends Immunol. 22(11): 633–640. https://doi.org/10.1016/s1471-4906(01)02060-9. |
| [38] | Zhang, Q., Bi, J., Zheng, X., et al. (2018). Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat. Immunol. 19(7): 723–732. https://doi.org/10.1038/s41590-018-0132-0. |
| [39] | Taveirne, S., Wahlen, S., Van Loocke, W., et al. (2020). The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation. Blood 136(3): 288–298. https://doi.org/10.1182/blood.2020005204. |
| [40] | Yang, C., Siebert, J.R., Burns, R., et al. (2019). Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat. Commun. 10(1): 3931. https://doi.org/10.1038/s41467-019-11947-7. |
| [41] | Smith, S.L., Kennedy, P.R., Stacey, K.B., et al. (2020). Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing. Blood Adv. 4(7): 1388–1406. https://doi.org/10.1182/bloodadvances.2019000699. |
| [42] | Marçais, A., Cherfils-Vicini, J., Viant, C., et al. (2014). The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15(8): 749–757. https://doi.org/10.1038/ni.2936. |
| [43] | Chiossone, L., Vitale, C., Cottalasso, F., et al. (2007). Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood 109(9): 3767–3775. https://doi.org/10.1182/blood-2006-07-037846. |
| [44] | Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation. Cell 140(6): 805–820. https://doi.org/10.1016/j.cell.2010.01.022. |
| [45] | van den Bosch, T.P.P., Kannegieter, N.M., Hesselink, D.A., et al. (2017). Targeting the Monocyte-Macrophage Lineage in Solid Organ Transplantation. Front. Immunol. 8: 153. https://doi.org/10.3389/fimmu.2017.00153. |
| [46] | Ginhoux, F., and Jung, S. (2014). Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14(6): 392–404. https://doi.org/10.1038/nri3671. |
| [47] | Patel, A.A., Zhang, Y., Fullerton, J.N., et al. (2017). The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J. Exp. Med. 214(7): 1913–1923. https://doi.org/10.1084/jem.20170355. |
| [48] | Hop, H.T., Arayan, L.T., Huy, T.X.N., et al. (2018). The Key Role of c-Fos for Immune Regulation and Bacterial Dissemination in Brucella Infected Macrophage. Front. Cell. Infect. Microbiol. 8: 287. https://doi.org/10.3389/fcimb.2018.00287. |
| [49] | Larsen, S.B., Cowley, C.J., Sajjath, S.M., et al. (2021). Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 28(10): 1758–1774.e8. https://doi.org/10.1016/j.stem.2021.07.001. |
| [50] | Rosenberg, H.F., Tenen, D.G., and Ackerman, S.J. (1989). Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc. Natl. Acad. Sci. USA 86(12): 4460–4464. https://doi.org/10.1073/pnas.86.12.4460. |
| [51] | Okoye, I., Xu, L., Motamedi, M., et al. (2020). Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors. J. Immunother. Cancer 8(2): e001849. https://doi.org/10.1136/jitc-2020-001849. |
| [52] | Motamedi, M., Shahbaz, S., Fu, L., et al. (2019). Galectin-9 Expression Defines a Subpopulation of NK Cells with Impaired Cytotoxic Effector Molecules but Enhanced IFNg Production, Dichotomous to TIGIT, in HIV-1 Infection. Immunohorizons 3(11): 531–546. https://doi.org/10.4049/immunohorizons.1900087. |
| [53] | Golden-Mason, L., McMahan, R.H., Strong, M., et al. (2013). Galectin-9 functionally impairs natural killer cells in humans and mice. J. Virol. 87(9): 4835–4845. https://doi.org/10.1128/JVI.01085-12. |
| [54] | Sánchez-Fueyo, A., and Strom, T.B. (2011). Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 140(1): 51–64. https://doi.org/10.1053/j.gastro.2010.10.059. |
| [55] | Wiesner, R.H., and Fung, J.J. (2011). Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl. 17(Suppl 3): S1–S9. https://doi.org/10.1002/lt.22410. |
| [56] | Wang, Z.-X., Song, S.-H., Teng, F., et al. (2010). A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma. Clin. Transplant. 24(6): 752–757. https://doi.org/10.1111/j.1399-0012.2009.01172.x. |
| [57] | Li, C.-J., and Li, L. (2015). Tacrolimus in preventing transplant rejection in Chinese patients–optimizing use. Drug Des. Devel. Ther. 9: 473–485. https://doi.org/10.2147/DDDT.S41349. |
| [58] | Liu, Y., Zhang, C., Li, L., et al. (2019). Genome-Wide Association Study of Tacrolimus Pharmacokinetics Identifies Novel Single Nucleotide Polymorphisms in the Convalescence and Stabilization Periods of Post-transplant Liver Function. Front. Genet. 10: 528. https://doi.org/10.3389/fgene.2019.00528. |
| [59] | Yu, S., Su, C., and Luo, X. (2019). Impact of infection on transplantation tolerance. Immunol. Rev. 292(1): 243–263. https://doi.org/10.1111/imr.12803. |
| [60] | Wood, K.J., and Goto, R. (2012). Mechanisms of rejection: current perspectives. Transplantation 93(1): 1–10. https://doi.org/10.1097/TP.0b013e31823cab44. |
| [61] | Li, H., Yu, X., Shi, B., et al. (2021). Reduced pannexin 1-IL-33 axis function in donor livers increases risk of MRSA infection in liver transplant recipients. Sci. Transl. Med. 13(606): eaaz6169. https://doi.org/10.1126/scitranslmed.aaz6169. |
| [62] | Rodríguez-Perálvarez, M., Tsochatzis, E., Naveas, M.C., et al. (2013). Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma. J. Hepatol. 59(6): 1193–1199. https://doi.org/10.1016/j.jhep.2013.07.012. |
| [63] | Marik, P.E., and Flemmer, M. (2012). The immune response to surgery and trauma: Implications for treatment. J. Trauma Acute Care Surg. 73(4): 801–808. https://doi.org/10.1097/TA.0b013e318265cf87. |
| [64] | Gao, J., Duan, Z., Zhang, L., et al. (2016). Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. OncoImmunology 5(1): e1048061. https://doi.org/10.1080/2162402X.2015.1048061. |
| [65] | Rodríguez-Perálvarez, M., Germani, G., Papastergiou, V., et al. (2013). Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. J. Hepatol. 58(2): 262–270. https://doi.org/10.1016/j.jhep.2012.09.019. |
| [66] | Montano-Loza, A.J., Rodríguez-Perálvarez, M.L., Pageaux, G.-P., et al. (2023). Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation. J. Hepatol. 78(6): 1199–1215. https://doi.org/10.1016/j.jhep.2023.01.030. |
| [67] | Charlton, M., Levitsky, J., Aqel, B., et al. (2018). International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation 102(5): 727–743. https://doi.org/10.1097/TP.0000000000002147. |
| [68] | (2016). EASL Clinical Practice Guidelines: Liver transplantation. J. Hepatol. 64(2): 433–485. https://doi.org/10.1016/j.jhep.2015.10.006. |
| [69] | Taubert, R., Hardtke-Wolenski, M., Noyan, F., et al. (2014). Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. J. Hepatol. 61(5): 1106–1114. https://doi.org/10.1016/j.jhep.2014.05.034. |
| [70] | Adams, D.H., Sanchez-Fueyo, A., and Samuel, D. (2015). From immunosuppression to tolerance. J. Hepatol. 62(1 Suppl): S170–S185. https://doi.org/10.1016/j.jhep.2015.02.042. |
| [71] | Knechtle, S.J., and Kwun, J. (2009). Unique aspects of rejection and tolerance in liver transplantation. Semin. Liver Dis. 29(1): 91–101. https://doi.org/10.1055/s-0029-1192058. |
| [72] | Ogura, Y., Martinez, O.M., Villanueva, J.C., et al. (2001). Apoptosis and allograft rejection in the absence of CD8+ T cells. Transplantation 71(12): 1827–1834. https://doi.org/10.1097/00007890-200106270-00020. |
| [73] | Navarro, F., Portalès, P., Candon, S., et al. (2000). Natural killer cell and alphabeta and gammadelta lymphocyte traffic into the liver graft immediately after liver transplantation. Transplantation 69(4): 633–639. https://doi.org/10.1097/00007890-200002270-00027. |
| [74] | Moroso, V., Metselaar, H.J., Mancham, S., et al. (2010). Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transpl. 16(7): 895–908. https://doi.org/10.1002/lt.22080. |
| [75] | Halloran, P.F., Afrouzian, M., Ramassar, V., et al. (2001). Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am. J. Pathol. 158(1): 215–226. https://doi.org/10.1016/s0002-9440(10)63960-0. |
| [76] | Millán, O., Rafael-Valdivia, L., San Segundo, D., et al. (2014). Should IFN-g, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study. Clin. Immunol. 154(2): 141–154. https://doi.org/10.1016/j.clim.2014.07.007. |
| [77] | Cui, A., Li, B., Wallace, M.S., et al. (2024). Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis. J. Hepatol. 80: 251–267. https://doi.org/10.1016/j.jhep.2023.02.040. |
| Wang R., Peng X., Yuan Y., et al., (2024). Dynamic immune recovery process after liver transplantation revealed by single-cell multi-omics analysis. The Innovation 5(3), 100599. https://doi.org/10.1016/j.xinn.2024.100599 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Study design
Definition of a four-phase recovery process in LT
Global changes in immune cells across the four-phase recovery process
Dynamic changes in subpopulations of T cells after LT
Heterogeneity of NK cells across the LT recovery process
Dynamics of monocytic subpopulations across LT
Multicellular interaction analysis after LT
A schematic illustration of a four-phase framework that aids in the clinical management of LT patients